Evaluation of neutrophil/lymphocyte and platelet/ lymphocyte ratios in sudden sensorineural hearing loss and relationship with hyperbaric oxygen therapy
| dc.contributor.author | Çiçek, Tolga | |
| dc.contributor.author | Acar, Gül Özbilen | |
| dc.contributor.author | Özdamar, Osman İlkay | |
| dc.date.accessioned | 2025-05-10T15:24:16Z | |
| dc.date.issued | 2021 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | OBJECTIVE: This study aimed to evaluate the prognostic value of neutrophil/lymphocyte (N/L) and platelet/lymphocyte (P/L) ratios in sudden sensorineural hearing loss (SSNHL) and investigate the effect of combined corticosteroid medical treatment and/or hyperbaric oxygen (HBO) therapy on these values. METHODS: In this study, patients with SSHL at our tertiary center were examined retrospectively. A total of 60 patients with SSNHL and 30 healthy individuals as the control group were included. The patient and control groups were compared in terms of N/L and P/L rates. Furthermore, 60 patients were divided into 2 equal groups (n=30) on the basis of whether they received HBO in addition to combined corticosteroid treatment. RESULTS: The N/L and P/L rates were significantly higher in the patient groups than in the control group at the time of diagnosis and significantly decreased after treatment in the patient groups (p<0.05). It was observed that HBO therapy lowered the N/L and P/L rates more than the HBO-free group, but the statistically significant decrease was only in N/L ratio (p<0.05). CONCLUSION: The N/L and P/L rates were higher in the patient groups than in the control group, and there was also a significant decrease in the 2 values after treatment. This was an important finding showing that SSNHL has a possible underlying inflammatory and vascular (ischemic) condition. We also found that the higher the P/L ratio, the lower the recovery rate from hearing loss. This finding suggests that the P/L ratio can be an important prognostic indicator in patients with SSNHL. © 2021, AVES. All rights reserved. | |
| dc.identifier.doi | 10.5152/iao.2020.7943 | |
| dc.identifier.endpage | 102 | |
| dc.identifier.issn | 1308-7649 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pmid | 33893777 | |
| dc.identifier.scopus | 2-s2.0-85105398856 | |
| dc.identifier.scopusquality | Q3 | |
| dc.identifier.startpage | 96 | |
| dc.identifier.uri | https://doi.org/10.5152/iao.2020.7943 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/6680 | |
| dc.identifier.volume | 17 | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | AVES | |
| dc.relation.ispartof | Journal of International Advanced Otology | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.snmz | KA_Scopus_20250302 | |
| dc.subject | Hyperbaric oxygen therapy; Inflammation; Neutrophil lymphocyte ratio; Platelet; Sudden hearing loss | |
| dc.title | Evaluation of neutrophil/lymphocyte and platelet/ lymphocyte ratios in sudden sensorineural hearing loss and relationship with hyperbaric oxygen therapy | |
| dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1










